Dr. Steven Pergam

For the Media

Dr. Steven Pergam

Dr. Steven Pergam is a member of Fred Hutch's Vaccine and Infectious Disease Division and director of infectious disease prevention at the Seattle Cancer Care Alliance. He conducts research on the prevention of infections in patients with cancer, transplant recipients and others who are immunocompromised.

Resources for more information

  • Overview of Steven Pergam's Research
    Comparative effectiveness analysis; cost effectiveness analysis, health economics, cancer outcomes research.
  • Steven Pergam – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • Pergam Group
    The Pergam Group collaborates on projects to understand the risk factors and outcomes of cancer and transplants pateints, the risk of cytomegalovirus and the risk of drug resistance and healthcare-associated infections.
  • Vaccine and Infectious Disease Division
    VIDD’s research aims at preventing, diagnosing, treating and understanding infectious diseases. There is a wide range of research topics under investigation across the fields of biology, medicine and public health. VIDD is organized into four research programs that integrate multiple research interests.


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


Photos / Graphics / Video


Download photos of Steven Pergam.

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.